UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number: 001-36073

 

Enzymotec Ltd.

 

(Exact name of registrant as specified in its charter)

 

Enzymotec Ltd.

Sagi 2000 Industrial Area

P.O. Box 6

Migdal Ha’Emeq 2310001, Israel

+972 (74) 7177-177

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Ordinary shares, par value NIS 0.01 per share

(Title of each class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

  Rule 12g-4(a)(1) x
  Rule 12g-4(a)(2) ¨
  Rule 12h-3(b)(1)(i) x
  Rule 12h-3(b)(1)(ii) ¨
  Rule 15d-6 ¨
  Rule 15d-22(b) ¨

 

Approximate number of holders of record as of the certificate or notice date: One (1)

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Enzymotec Ltd. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

        Enzymotec Ltd.
       
Date: January 22, 2018       By:  

/s/ Dror Israel

        Name:   Dror Israel
        Title:   Chief Financial Officer

 

 

 


ENZYMOTEC LTD. (NASDAQ:ENZY)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024 ENZYMOTEC LTD. 차트를 더 보려면 여기를 클릭.
ENZYMOTEC LTD. (NASDAQ:ENZY)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024 ENZYMOTEC LTD. 차트를 더 보려면 여기를 클릭.